Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.12

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.8

Views

Views
May 20244
June 20241
July 20240
August 20243
September 20240
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom1
 

Top cities views

Views
Ashburn1
Chicago1
Prineville1